Hi everyone, welcome to my blog where I share the latest news and updates on fibromyalgia, a chronic pain disorder that affects millions of people around the world. In this post, I want to talk about some of the new research on fibromyalgia that has been published in 2023. Here are some of the highlights:
- A study from Ruhr University Bochum, Germany, found that fibromyalgia patients have impaired pain modulation in their brains, meaning that they don't feel like they can control their pain as well as healthy people do. The researchers used functional magnetic resonance imaging (fMRI) to measure brain activity while the participants were exposed to heat pain. They found that healthy people activated certain frontal brain areas that help modulate pain when they could terminate the pain stimulus themselves, but fibromyalgia patients did not show any such activation. The researchers suggest that this could explain why fibromyalgia patients have reduced quality of life and need more cognitive resources to cope with acute pain.
- A team of biomedical researchers from Queen Mary University of London, Hebrew University and University College London discovered a link between fibromyalgia-type symptoms and the migration of neutrophils into the muscles. Neutrophils are a type of white blood cell that are involved in inflammation and infection. The researchers used a mouse model of fibromyalgia and found that blocking the migration of neutrophils into the muscles reduced the pain and fatigue symptoms in the mice. They also found that fibromyalgia patients had higher levels of a protein called CXCL1 in their blood, which attracts neutrophils to the muscles. The researchers propose that targeting CXCL1 or neutrophil migration could be a new therapeutic strategy for fibromyalgia.
- A large grant of $9.5 million was awarded to the Hanson ME/CFS Research Center for Enervating Neuroimmune Disease at Cornell University to study the molecular mechanisms of fibromyalgia and chronic fatigue syndrome (ME/CFS). The grant came from one of the three NIH-funded ME/CFS research centers, which is a sign of recognition and support for these poorly understood conditions. The research team, led by Professor Maureen Hanson, will use cutting-edge technologies such as metabolomics, proteomics, genomics and epigenomics to identify biomarkers and pathways that are altered in fibromyalgia and ME/CFS patients. The goal is to improve diagnosis, treatment and prevention of these debilitating diseases.
These are just some of the exciting new developments in fibromyalgia research that have been reported in 2023. I hope you found this post informative and helpful. If you have any questions or comments, please feel free to leave them below. And don't forget to subscribe to my blog for more updates on fibromyalgia and related topics. Thanks for reading!

Comments
Post a Comment